ES2110375T3 - Nimesulida para uso externo. - Google Patents

Nimesulida para uso externo.

Info

Publication number
ES2110375T3
ES2110375T3 ES95933625T ES95933625T ES2110375T3 ES 2110375 T3 ES2110375 T3 ES 2110375T3 ES 95933625 T ES95933625 T ES 95933625T ES 95933625 T ES95933625 T ES 95933625T ES 2110375 T3 ES2110375 T3 ES 2110375T3
Authority
ES
Spain
Prior art keywords
external use
nimesulide
discoloration
safe
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933625T
Other languages
English (en)
Other versions
ES2110375T1 (es
Inventor
Satoru Miyata
Yasuaki Taniguchi
Kenji Masuda
Yoichi Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helsinn Healthcare SA
Original Assignee
Helsinn Healthcare SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare SA filed Critical Helsinn Healthcare SA
Publication of ES2110375T1 publication Critical patent/ES2110375T1/es
Application granted granted Critical
Publication of ES2110375T3 publication Critical patent/ES2110375T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Abstract

AGENTE ANTIINFLAMATORIO DE USO EXTERNO, QUE CONTIENE NIMESULIDO COMO INGREDIENTE ACTIVO DISPERSO EN EL COMPONENTE BASE Y QUE ES BIEN ABSORBIBLE, SEGURO Y LIBRE DE DECOLORACION.
ES95933625T 1994-10-05 1995-10-05 Nimesulida para uso externo. Expired - Lifetime ES2110375T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26829394 1994-10-05

Publications (2)

Publication Number Publication Date
ES2110375T1 ES2110375T1 (es) 1998-02-16
ES2110375T3 true ES2110375T3 (es) 2001-12-01

Family

ID=17456521

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933625T Expired - Lifetime ES2110375T3 (es) 1994-10-05 1995-10-05 Nimesulida para uso externo.

Country Status (17)

Country Link
US (1) US5837735A (es)
EP (1) EP0782855B1 (es)
KR (1) KR100339793B1 (es)
CN (1) CN1080561C (es)
AT (1) ATE205391T1 (es)
AU (1) AU701740B2 (es)
BR (1) BR9509183A (es)
CA (1) CA2201722A1 (es)
DE (2) DE782855T1 (es)
DK (1) DK0782855T3 (es)
ES (1) ES2110375T3 (es)
GE (1) GEP20002012B (es)
HK (1) HK1001374A1 (es)
MX (1) MXPA97002401A (es)
PT (1) PT782855E (es)
UA (1) UA42795C2 (es)
WO (1) WO1996011002A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
CN1095661C (zh) * 1996-07-23 2002-12-11 灵药生物技术有限公司 含尼美舒利的抗炎和止痛的透皮使用的治疗组合物和它们的制备方法
IT1289972B1 (it) 1997-02-25 1998-10-19 Helsinn Healthcare Sa Formulazioni topiche di nimesulide in forma di sistemi a cristalli liquidi
IT1289973B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1291997B1 (it) * 1997-05-26 1999-01-25 Schiena Michele Giuseppe Di Preparati-farmaceutici-topici-contenenti nimesulide
GB2340751B (en) 1998-08-12 2003-11-05 Edko Trading Representation Pharmaceutical compositions
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
AU1888900A (en) * 1999-05-31 2000-12-18 Shashikant Prabhudas Kurani A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
US6702733B1 (en) 1999-07-01 2004-03-09 40 J's Llc Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
US6203796B1 (en) 1999-07-08 2001-03-20 Andreas D. Papaprodromou Oregano-based therapeutic composition
US8609412B2 (en) * 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
IN191512B (es) * 2000-01-21 2003-12-06 Panacea Biotech
IT1318588B1 (it) * 2000-06-20 2003-08-27 Helsinn Healthcare Sa Uso della nimesulide nel trattamento di patologie dermatologiche.
HUP0302068A3 (en) * 2000-07-20 2005-05-30 Lauras As Use of cox-2 inhibitors for treating or preventing immunodeficiency and pharmaceutical compositions containing them
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US20030059450A1 (en) * 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
US6548545B1 (en) 2001-10-01 2003-04-15 40 J's Llc Treatment of interstitial cystitis using topical application of menthol and L-arginine
EP1684725A1 (en) * 2003-10-31 2006-08-02 Elan Pharma International Limited Novel nimesulide compositions
CZ297215B6 (cs) * 2005-04-06 2006-10-11 Zentiva, A. S. Topická léková forma s obsahem nimesulidu
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
TR200906775A1 (tr) 2009-09-02 2011-03-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Nimesulid ve kas gevşetici kombinasyonları
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2636405B1 (en) * 2010-11-02 2018-03-14 Teikoku Seiyaku Co., Ltd. Felbinac-containing external patch
JP5826075B2 (ja) * 2012-03-08 2015-12-02 株式会社ナリス化粧品 化粧料
JP6213975B2 (ja) * 2012-09-13 2017-10-18 テイカ製薬株式会社 薬物含有超極細ファイバーおよびその利用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826845A (en) * 1969-02-08 1974-07-30 Sankyo Co Ointment base
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
JPS55139313A (en) * 1979-04-16 1980-10-31 Ota Seiyaku Kk Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it
EP0182881A1 (en) * 1984-06-11 1986-06-04 WEINER, Murray Topical compositions
IT1248475B (it) * 1990-05-22 1995-01-19 Angeli Inst Spa Composti di inclusione di nimesulide con ciclodestrine
US5432170A (en) * 1991-07-16 1995-07-11 Schering Aktiengesellschaft Process for the production of semisolid preparations containing micronized active ingredients
JPH10257192A (ja) * 1997-03-14 1998-09-25 Fujitsu Ltd コールバック式受付処理方法及び装置

Also Published As

Publication number Publication date
GEP20002012B (en) 2000-04-10
DE69522696T2 (de) 2002-04-18
AU701740B2 (en) 1999-02-04
CA2201722A1 (en) 1996-04-18
ATE205391T1 (de) 2001-09-15
DE782855T1 (de) 1998-05-28
PT782855E (pt) 2001-12-28
EP0782855A4 (en) 1997-09-10
DE69522696D1 (de) 2001-10-18
CN1162262A (zh) 1997-10-15
KR970706016A (ko) 1997-11-03
BR9509183A (pt) 1997-12-30
UA42795C2 (uk) 2001-11-15
EP0782855A1 (en) 1997-07-09
US5837735A (en) 1998-11-17
WO1996011002A1 (fr) 1996-04-18
AU3619295A (en) 1996-05-02
KR100339793B1 (ko) 2002-07-18
CN1080561C (zh) 2002-03-13
HK1001374A1 (en) 1998-06-19
ES2110375T1 (es) 1998-02-16
EP0782855B1 (en) 2001-09-12
MXPA97002401A (es) 2004-08-20
DK0782855T3 (da) 2001-12-27

Similar Documents

Publication Publication Date Title
ES2110375T3 (es) Nimesulida para uso externo.
PT698393E (pt) Agente de solubilizacao e preparacao para uso externo contendo o mesmo
ES2115733T3 (es) Composicion antialergica para uso oftalmico o nasal.
DE69007507D1 (de) Fungizides Mittel.
BR0003632B1 (pt) absorvente Íntimo adaptado para ser usado em uma porÇço entre as pernas de uma roupa debaixo.
FI963183A0 (fi) Vesipitoinen dispersiokoostumus, ja sitä käyttävä koostumus
KR920021513A (ko) N-펜타데실 니코티네이트 n-옥사이드 및 이를 포함하는 발모제
NL194456B (nl) Leidgestel voor gebruik bij de vervaardiging van halfgeleiderinrichtingen, voorzien van eerste en tweede positioneerorganen.
DE69003598D1 (de) Melanogenese-inhibitierendes mittel zur aeusserlichen anwendung.
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
ES2152315T3 (es) Xamoneline tartrato.
TR199700409T1 (xx) Harici kullan�ma mahsus enflamasyon �nleyici madde.
ES2112978T3 (es) Composicion de polimeros para aplicaciones medicas.
NL1007839A1 (nl) Formulering en gebruik.
BR9303817A (pt) Uso, dispositivos mecânicos e agentes para o combate de baratas
BR9303738A (pt) Agente conservante, agente injetável e uso
DE68927006T2 (de) Turboblasvorrichtung für laser und laseroszillator, der diese verwendet
RU97122120A (ru) Средство для лечения системной красной волчанки
ES1009203Y (es) Dispositivo ambientador perfeccionado.
DE60008536D1 (de) Topische antiseptische zusammensetzung
ES1034788Y (es) Estructura perfeccionada para mesa o similar.
ES1030626Y (es) Dispositivo de ruleta para juego de mesa.
ES1024402Y (es) Dispositivo ambientador perfeccionado.
ES1027259Y (es) Mesa para ordenador perfeccionado.
ES1010805Y (es) Mesa para futbolin perfeccionada.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 782855

Country of ref document: ES